TM2.F vs. NOV.DE
Compare and contrast key facts about Sydbank A/S (TM2.F) and Novo Nordisk A/S (NOV.DE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TM2.F or NOV.DE.
Key characteristics
| TM2.F | NOV.DE | |
|---|---|---|
| YTD Return | 178.10% | 37.28% |
| 1Y Return | 147.77% | 49.18% |
| 3Y Return (Ann) | 139.52% | 53.42% |
| 5Y Return (Ann) | 97.23% | 54.72% |
| 10Y Return (Ann) | 59.81% | 44.07% |
| Sharpe Ratio | 1.15 | 1.57 |
| Daily Std Dev | 119.10% | 31.58% |
| Max Drawdown | -76.16% | -87.90% |
| Current Drawdown | -11.25% | -11.70% |
Fundamentals
| TM2.F | NOV.DE | |
|---|---|---|
| Market Cap | €2.34B | €545.45B |
| EPS | €8.35 | €2.69 |
| PE Ratio | 5.32 | 45.49 |
| PEG Ratio | 0.00 | 2.07 |
| Total Revenue (TTM) | €7.66B | €93.49B |
Correlation
The correlation between TM2.F and NOV.DE is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TM2.F vs. NOV.DE - Performance Comparison
In the year-to-date period, TM2.F achieves a 178.10% return, which is significantly higher than NOV.DE's 37.28% return. Over the past 10 years, TM2.F has outperformed NOV.DE with an annualized return of 59.81%, while NOV.DE has yielded a comparatively lower 44.07% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TM2.F vs. NOV.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sydbank A/S (TM2.F) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TM2.F vs. NOV.DE - Dividend Comparison
TM2.F's dividend yield for the trailing twelve months is around 9.14%, more than NOV.DE's 1.12% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TM2.F Sydbank A/S | 9.14% | 5.81% | 4.09% | 4.74% | 7.14% | 6.84% | 7.52% | 4.25% | 1.48% | 3.21% | 0.00% | 0.00% |
NOV.DE Novo Nordisk A/S | 1.12% | 1.01% | 1.18% | 1.27% | 1.99% | 2.09% | 5.96% | 2.28% | 3.69% | 1.25% | 1.69% | 1.82% |
Drawdowns
TM2.F vs. NOV.DE - Drawdown Comparison
The maximum TM2.F drawdown since its inception was -76.16%, smaller than the maximum NOV.DE drawdown of -87.90%. Use the drawdown chart below to compare losses from any high point for TM2.F and NOV.DE. For additional features, visit the drawdowns tool.
Volatility
TM2.F vs. NOV.DE - Volatility Comparison
The current volatility for Sydbank A/S (TM2.F) is 6.29%, while Novo Nordisk A/S (NOV.DE) has a volatility of 6.66%. This indicates that TM2.F experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TM2.F vs. NOV.DE - Financials Comparison
This section allows you to compare key financial metrics between Sydbank A/S and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities